Eton Pharmaceuticals Income Statement (2019-2025) | ETON

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.50M0.46M0.10M0.02M0.16M-0.00M11.90M3.07M0.78M6.09M2.18M5.00M3.22M8.50M5.30M12.00M7.03M29.80M7.97M9.07M10.32M11.65M1.79M18.93M22.46M
Cost of Revenue 0.45M0.10M0.03M0.14M0.27M1.59M0.17M0.65M0.37M0.85M2.75M1.20M2.14M1.96M2.31M2.62M3.68M2.96M3.45M4.02M5.17M0.68M7.00M14.60M
Gross Profit 0.50M0.01M-0.00M-0.01M-0.02M-0.22M10.31M2.89M0.12M5.72M1.33M4.61M2.02M6.36M3.35M9.68M4.40M3.63M5.01M5.63M6.30M6.48M9.86M11.92M7.86M
Operating items
Research & Development 6.46M1.44M3.42M0.23M6.27M1.61M2.83M3.40M0.89M1.99M2.68M0.68M1.62M0.69M0.74M0.94M0.54M1.12M0.61M1.05M0.65M2.97M0.51M-0.87M1.16M3.71M1.11M
Selling, General & Administrative 1.59M1.91M1.62M2.43M2.61M2.92M3.43M3.80M4.06M3.23M3.29M3.73M4.80M5.26M4.17M4.35M5.34M4.67M4.34M4.58M5.16M5.59M5.29M6.72M9.17M9.69M8.11M
Operating Expenses 8.05M3.35M5.04M2.66M8.88M4.53M6.25M7.20M4.94M5.22M5.97M4.41M6.41M5.95M4.91M5.30M5.88M5.80M4.95M5.62M5.81M8.56M5.79M5.85M10.33M13.40M9.22M
Operating Income -7.55M-3.35M-5.04M-2.66M-8.88M-4.54M-6.27M-7.42M5.36M-2.33M-5.85M1.31M-5.09M-1.34M-2.90M1.06M-2.53M3.88M-0.55M-1.99M-0.80M-2.94M0.51M0.63M-0.47M-1.48M-1.36M
EBIT -7.55M-3.35M-5.04M-2.66M-8.88M-4.54M-6.27M-7.42M5.36M-2.33M-5.85M1.31M-5.09M-1.34M-2.90M1.06M-2.53M3.88M-0.55M-1.99M-0.80M-2.94M0.51M0.63M-0.47M-1.48M-1.36M
Non-operating items
Interest & Investment Income 0.14M0.10M0.08M-0.04M-0.13M-0.12M-0.03M-0.01M-0.05M-0.01M-1.03M-1.04M-0.59M
Other Non Operating Income 0.80M-0.80M0.17M
Non Operating Income 0.14M0.10M0.08M-0.04M0.17M-0.19M-0.23M-0.27M-0.25M-0.24M-0.25M-0.28M-0.24M-0.22M-0.15M-0.15M-0.13M0.68M-0.03M-0.02M-0.01M-0.05M-0.01M-1.14M
Net income details
EBT -7.41M-3.25M-4.96M-2.70M-9.05M-4.73M-6.50M-7.69M5.12M-2.02M-6.09M1.04M-5.33M-1.56M-3.04M0.91M-2.66M4.56M-0.58M-2.01M-0.81M-2.99M0.50M-0.51M-1.50M-2.52M-1.96M
Tax Provisions 0.25M0.05M-0.13M0.09M0.07M0.07M-0.03M
Profit After Tax -7.41M-3.25M-4.96M-2.70M-9.05M-4.73M-6.50M-7.69M5.12M-2.02M-6.09M1.04M-5.33M-1.56M-3.04M0.91M-2.66M4.56M-0.58M-2.26M-0.81M-3.04M0.63M-0.60M-1.57M-2.58M-1.93M
Income from Continuing Operations -7.41M-3.25M-4.96M-2.70M-9.05M-4.73M-6.50M-7.69M5.12M-2.02M-6.09M1.04M-5.33M-1.56M-3.04M0.91M-2.66M4.56M-0.58M-2.26M-0.81M-3.04M0.63M-0.60M-1.57M-2.58M-1.93M
Consolidated Net Income -7.41M-3.25M-4.96M-2.70M-9.05M-4.73M-6.50M-7.69M5.12M-2.02M-6.09M1.04M-5.33M-1.56M-3.04M0.91M-2.66M4.56M-0.58M-2.26M-0.81M-3.04M0.63M-0.60M-1.57M-2.58M-1.93M
Income towards Parent Company -7.41M-3.25M-4.96M-2.70M-9.05M-4.73M-6.50M-7.69M5.12M-2.02M-6.09M1.04M-5.33M-1.56M-3.04M0.91M-2.66M4.56M-0.58M-2.26M-0.81M-3.04M0.63M-0.60M-1.57M-2.58M-1.93M
Net Income towards Common Stockholders -7.41M-3.25M-4.96M-2.70M-9.05M-4.73M-6.50M-7.69M5.12M-2.02M-6.09M1.04M-5.33M-1.56M-3.04M0.91M-2.66M4.56M-0.58M-2.26M-0.81M-3.04M0.63M-0.60M-1.57M-2.58M-1.93M
Additional items
EPS (Basic) -0.42-0.18-0.28-0.15-0.50-0.23-0.31-0.320.21-0.08-0.240.04-210.00-0.06-0.120.04-0.100.18-0.02-0.09-0.03-0.120.02-0.03-0.06-0.10-0.07
EPS (Weighted Average and Diluted) -0.50-0.230.19-0.08-0.24-0.21-0.06-0.12-0.100.18-0.02-0.03-0.120.02-0.07
Shares Outstanding (Weighted Average) 17.63M17.63M17.76M17.81M17.88M20.92M20.96M24.21M24.41M24.51M24.60M24.61M24.63M25.22M25.30M25.30M25.46M25.50M25.65M25.66M25.69M25.69M25.84M25.84M26.82M26.82M26.82M
Shares Outstanding (Diluted Average) 18.14M21.00M26.55M0.03M25.28M25.30M25.13M25.36M0.03M0.03M0.03M0.03M0.03M26.55M26.89M
EBITDA -7.55M-3.35M-5.04M-2.66M-8.88M-4.54M-6.27M-7.42M5.36M-2.33M-5.85M1.31M-5.09M-1.34M-2.90M1.06M-2.53M3.88M-0.55M-1.99M-0.80M-2.94M0.51M0.63M-0.47M-1.48M-1.36M
Tax Rate 1.43%